Your browser doesn't support javascript.
loading
Immunogenicity and safety of SARS-CoV-2 vaccine with immunosuppressive agents.
Kamei, Koichi; Ogura, Masao; Sato, Mai; Nishi, Kentaro; Shoji, Kensuke; Funaki, Takanori; Ogimi, Chikara; Ito, Shuichi.
Afiliación
  • Kamei K; Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
  • Ogura M; Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
  • Sato M; Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
  • Nishi K; Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan.
  • Shoji K; Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
  • Funaki T; Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
  • Ogimi C; Division of Infectious Diseases, National Center for Child Health and Development, Tokyo, Japan.
  • Ito S; Department of Pediatrics, Yokohama City University Hospital, Kanagawa, Japan.
Pediatr Int ; 64(1): e15331, 2022 Jan.
Article en En | MEDLINE | ID: mdl-36331234

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Pediatr Int Asunto de la revista: PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Pediatr Int Asunto de la revista: PEDIATRIA Año: 2022 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Australia